Will the Phase 2 trial "JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)" reach primary completion on or before Sep 30, 2026?

Resolves Yes if ClinicalTrials.gov record NCT06675422 (920th Hospital of Joint Logistics Support Force of People's Liberation Army of China) shows an actual primary completion date on or before Sep 30, 2026. Registered date at generation: Sep 30, 2026.

Outcome verified from clinicaltrials.gov.

1. Market open

   Jul 17, 2026, 7:40 AM UTC
2. Market closes

   By Sep 30, 2026, 11:59 PM UTC
3. Projected payout

   Shortly after the market closes

Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.